Steven Gannon

Steven Gannon is currently Director at enGene, Inc. since 2017, Independent Director at Xenon Pharmaceuticals, Inc. since 2015, and Director at Altasciences Co., Inc. since 2021.
Former roles include Director at 2941881 Canada, Inc., Director-Finance & Administration at AstraZeneca Canada, Inc. from 1996 to 1999, Director at Aerogen Ltd. from 2018 to 2020, Independent Non-Executive Director at Advanced Accelerator Applications SA from 2014 to 2018, Treasurer & Director at Multiple Myeloma Canada, Independent Director at Fusion Pharmaceuticals, Inc. from 2020 to 2024, Chief Financial Officer at CryoCath Technologies, Inc. from 1999 to 2006, Chief Financial Officer, Treasurer & Senior VP at Aptalis Pharma LLC from 2011 to 2014, Chief Financial Officer at Mallinckrodt Medical, Inc. from 1989 to 1995, and Chief Financial Officer, Treasurer & Senior VP at Aptalis Holdings, Inc. in 2008.
Education includes an undergraduate degree from Concordia University conferred in 1983.